Unclassified pediatric renal stromal tumor overlapping with metanephric stromal tumor and solitary fibrous tumor with diffuse S-100 protein expression

• Published in: Pathology, research and practice Vol. 207; no. 11; pp. 707 - 711
• Main Authors: Brancato, Franca, Gurrera, Alessandra, Bisceglia, Michele, Alaggio, Rita, Di Cataldo, Andrea, Di Benedetto, Vincenzo, Magro, Gaetano
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 15-11-2011
• Subjects: Biomarkers, Tumor - metabolism; Child; Diagnosis, Differential; Humans; Immunohistochemistry; Kidney; Kidney - metabolism; Kidney - pathology; Kidney Neoplasms - pathology; Kidney Neoplasms - surgery; Male; Metanephric stromal tumor; Nephrectomy; S-100 protein; S100 Proteins - metabolism; Solitary fibrous tumor; Solitary Fibrous Tumors - pathology; Solitary Fibrous Tumors - surgery; Stromal Cells - pathology; Treatment Outcome; Vimentin - metabolism; Immunohistochemistry; Solitary fibrous tumor; S-100 protein; Metanephric stromal tumor; Kidney
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2011.07.008

Metanephric stromal tumor (MST) is a rare pediatric neoplasm unique to the kidneys that is currently included in the spectrum of metanephric tumors, along with metanephric adenoma and adenofibroma. We herein report an unusual case of pediatric renal stromal tumor overlapping with MST and solitary fibrous tumor (SFT). Histologically, the tumor was composed of bland-looking spindle to stellate cells embedded in a fibro-sclerotic stroma that focally surrounded native entrapped renal tubules or blood vessels with abortive rings or collarettes. Alternating hypercellular and hypocellular areas and a focal hemangiopericytomatous-like vascular pattern imparted to the tumor a resemblance to SFT. Angiodysplasia of intratumoral arterioles was also observed, but juxtaglomerular cell hyperplasia was not a feature. Immunohistochemically, the neoplastic cells showed a polyphenotypic profile, including diffuse expression of vimentin and CD34, and focal immunoreactivity for alpha-smooth muscle actin, EMA, and CD99. However, the most striking finding was diffuse nuclear and cytoplasmic expression of S-100 protein. Although this protein has been reported to stain the heterologous glial and/or cartilaginous components that can be occasionally encountered in MST, this marker has not been previously reported in the fibroblastic component of MST. Pathologist should be aware of similar unusual unclassified tumors to avoid potential confusion with other benign or malignant S-100 protein-positive tumors.